Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LunaRx vs NiceRx

By GLP-1 ScorecardUpdated

LunaRxFactor scores not reassessed.
Site position #327

Lower score

NiceRxFactor scores not reassessed.
Site position #220

Higher score

Score comparison

NiceRx has the higher recorded score — 66.1/100 to 61.2/100.

NiceRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NiceRx (NiceRx LLC) offers compounded semaglutide ($199/mo) and compounded tirzepatide ($299/mo) with first-month promos.

Before you choose

Before comparing the headline prices, the LunaRx review and the NiceRx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, LunaRx vs Piper and Neo Soma Healthcare vs NiceRx compare each of them with another graded program, and the list of alternatives to LunaRx ranks the programs closest to LunaRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the WellMedr review covers one graded close to these two, at 63.2/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEven
54
54
Dose & formulationNiceRx +12
52
64
Clinical oversightNiceRx +4
82
86
Labs & monitoringLunaRx +1
54
53
FulfillmentNiceRx +15
70
85
Contract termsEven
55
55
LunaRx · top barNiceRx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricLunaRxNiceRx
WeighScore61.2/10066.1/100
GradeCC
Site position#327#220
Semaglutide$199/mo (starting dose, compounded)$199/mo (compounded)
TirzepatideNot disclosed$299/mo (compounded)
CoverageCoverage not published46 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
LunaRx

Site position #327 · C

Factor scores not reassessed.

Strengths

  • Pairs GLP-1 with muscle-protective peptides (e.g., CJC-1295/Ipamorelin, NAD+) to defend lean mass during fat loss
  • Structured, physician-directed off-ramp taper with GI-reset support instead of an indefinite prescription
  • Bilingual care in English and Spanish across intake, messaging, and consults
  • Care directed through a named independent medical group (CareNexus Clinic PC); $0 charged if you are not approved
  • Published clinical support hours (Mon–Fri, CT) with phone, email, and secure messaging; cancel anytime

What to consider

  • Only a "from $199/mo" starting price is published; tirzepatide and per-tier pricing are confirmed only after a provider review
  • Compounding pharmacy partners are not named on the site — a transparency gap
  • No LegitScript or PCAB verification is displayed
  • States served are not published; the site claims "telehealth nationwide" but the Terms limit service to states where LunaRx is licensed
  • Compounded medications are not FDA-approved (the site discloses this)
NiceRx

Site position #220 · C

Factor scores not reassessed.

Strengths

  • LegitScript approved
  • Named legal entity (NiceRx LLC) with Boca Raton FL address
  • First-month discount on both drugs
  • Every batch tested for sterility and potency
  • 46-state coverage

What to consider

  • Not available in Alaska, Mississippi, New Jersey, Kansas
  • Compounded only — no brand-name options
  • Broader platform (anti-aging, NAD+, B12)

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard